Inactive Instrument
Tricida, Inc. Stock
Stocks
TCDA
US89610F1012
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -99.90% |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 75 | 01/10/2013 |
| Director/Board Member | - | 09/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/23/22 A | Sell | Director | 131,879 | 0.2369% | ||
| 11/22/22 A | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% | |
| 11/22/22 A | OrbiMed Advisors Private Equity
| Sell | Company | 10,280,947 | 18.4680% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.90% | -99.92% | - | - | 580 | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +1.01% | -1.42% | +9.43% | +91.48% | 58.86B | ||
| +1.00% | +0.96% | +26.61% | +87.57% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| +0.09% | -1.74% | +82.62% | +57.61% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | -10.29% | -2.29% | +35.35% | +172.60% | 45B | |
| Weighted average by Cap. | -0.08% | -2.18% | +35.11% | +147.20% |
Employees
57
















